Benitec Biopharma Limited Operating Income Growth

Operating Income Growth of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending June 30, 2022 was -22.91% (a -360.93% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -71.1%
  • Annual Operating Income Growth for 2022 was -31.32% (a -51.2% decrease from previous year)
  • Annual Operating Income Growth for 2021 was -64.18% (a -84.74% decrease from previous year)
  • Annual Operating Income Growth for 2020 was -420.6% (a -426.45% decrease from previous year)
  • Twelve month Operating Income Growth ending June 30, 2022 was -31.32% (a -8.74% decrease compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -59.6% year-over-year
Trailing Operating Income Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-31.32% -34.32% -57.98% -77.52%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of Benitec Biopharma Limited

Most recent Operating Income Growthof BNTC including historical data for past 10 years.

Interactive Chart of Operating Income Growth of Benitec Biopharma Limited

Benitec Biopharma Limited Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -22.91% 8.78% -31.32%
2021 -48.36% -79.26% -33.22% -79.68% -64.18%
2020 -179.5% -21.53% -485.48% 44.34% -420.6%
2019 64.22% 128.84%
2018 -119.34%
2017 17.71% 73.77%
2016 125.94% -78.13%
2015 -28.92%
2014 -88.08%
2013 46.83%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology